Related Experiment Video
Updated: Aug 8, 2025

Experimental Model to Evaluate Resolution of Pneumonia
Published on: February 17, 2023
Experimental Model to Evaluate Resolution of Pneumonia
Andres Villabona-Rueda1, Daniel Wang2, Franco R D'Alessio3
1Division of Pulmonary Critical Care Medicine, Johns Hopkins University School of Medicine.
This study introduces a new mouse model for acute respiratory distress syndrome (ARDS) using bacterial pneumonia. The model helps investigate the immune response during lung injury and recovery.
Area of Science:
- * Pulmonary and critical care medicine
- * Infectious disease research
- * Pre-clinical animal modeling
Background:
- * Acute respiratory distress syndrome (ARDS) is a severe lung injury with high mortality.
- * Existing pre-clinical models fail to fully capture ARDS complexity.
- * Infectious pneumonia models offer a viable alternative for studying ARDS pathophysiology.
Purpose of the Study:
- * To develop and characterize a novel mouse model of ARDS induced by bacterial pneumonia.
- * To evaluate the model's utility in studying the immune landscape during lung injury and resolution.
Main Methods:
- * Intratracheal instillation of live Streptococcus pneumoniae and Klebsiella pneumoniae in C57BL6 mice.
- * Serial measurements of body weight, bronchoalveolar lavage (BAL) fluid analysis, and lung tissue harvesting.
- * Histology, bacterial quantification, and high-dimensional flow cytometry for immune cell profiling.
Main Results:
- * Successful induction of lung injury mimicking ARDS features via bacterial pneumonia.
- * Comprehensive characterization of lung inflammation, injury markers, and bacterial load.
- * Detailed analysis of immune cell populations and their dynamics during injury and recovery phases.
Conclusions:
- * The developed bacterial pneumonia model effectively recapitulates key pathophysiological aspects of ARDS.
- * This model serves as a valuable tool for investigating immune responses in ARDS.
- * Facilitates research into early and late resolution phases of lung injury.
More Related Videos
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
12:21A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
Published on: September 28, 2022
Related Concept Videos
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia III: Complications and Assessment
Pneumonia II: Pathophysiology
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...